Report copyright - La Lettre de linfectiologue Étude LEAGUE-1 : daclatasvir + simeprevir ± RBV dans les GT1 (1) DCV 30 mg x 1/j (dose réduite) + SMV 150 mg x 1/j + RBV fonction
Please pass captcha verification before submit form
Please pass captcha verification before submit form